A, N., K, A., F, O., S, M., M, H., A, A., . . . T, W. (2020). Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. Journal of neuro-oncology, 148(1), 17. https://doi.org/10.1007/s11060-020-03505-9
Chicago Style (17th ed.) CitationA, Natsume, et al. "Genetic Analysis in Patients with Newly Diagnosed Glioblastomas Treated with Interferon-beta Plus Temozolomide in Comparison with Temozolomide Alone." Journal of Neuro-oncology 148, no. 1 (2020): 17. https://doi.org/10.1007/s11060-020-03505-9.
MLA (9th ed.) CitationA, Natsume, et al. "Genetic Analysis in Patients with Newly Diagnosed Glioblastomas Treated with Interferon-beta Plus Temozolomide in Comparison with Temozolomide Alone." Journal of Neuro-oncology, vol. 148, no. 1, 2020, p. 17, https://doi.org/10.1007/s11060-020-03505-9.